B-Tg(hLILRB2/hLILRB3/hLILRB1/hLILRB4) mice
C57BL/6-Tg(RP11-634C1)1(CH17-401N15)1Bcgen/Bcgen • 112332

B-Tg(hLILRB2/hLILRB3/hLILRB1/hLILRB4) mice

Catalog Number
112332
Strain Name
C57BL/6-Tg(RP11-634C1)1(CH17-401N15)1Bcgen/Bcgen
Strain Background
C57BL/6
NCBI gene ID
Aliases
ILT2; LIR1; MIR7; PIRB; CD85J; ILT-2; LIR-1; MIR-7; PIR-B; ILT4; LIR2; CD85D; ILT-4; LIR-2; MIR10; MIR-10; HL9; ILT5; LIR3; PIRB; CD85A; ILT-5; LIR-3; PIR-B; B4; ILT3; LIR5; CD85K; ILT-3; LIR-5

이 페이지에서

  • Description
  • Phenotypic analysis
  • Efficacy
  • FAQ section

포스터

모두 보기

    출판물

      Description

      Inhibitory LILRBs (LILRB1–4): Leukocyte immunoglobulin-like receptors and targets for tumor microenvironment reprogramming 

      • Gene Information: LILRB1–4 (encoding CD85j, CD85d, CD85a, and CD85k, also known as ILT2/4/5/3) are protein-coding genes clustered on chromosome 19q13.42. They encode leukocyte immunoglobulin-like receptor subfamily B members, a class of ITIM-bearing cell-surface transmembrane receptors functioning as next-generation myeloid immune checkpoints. 
      • Protein Expression: LILRB1–4 are predominantly expressed on myeloid lineages, specifically tumor-associated macrophages, dendritic cells, and monocytes. While LILRB2–3 remain myeloid-restricted and LILRB4 marks monocytic AML blasts, LILRB1 uniquely extends to subsets of T and NK cells. 
      • Signaling Pathway: LILRB1–4 transduce inhibitory signals by binding cognate ligands (e.g., MHC-I, ANGPTLs, APOE, fibronectin) and engaging intrinsic cytoplasmic ITIM motifs to recruit SHP-1/2 phosphatases, dampening downstream activating kinase cascades. 
      • Therapeutic Inhibition: LILRB-targeted antagonist antibodies, bispecifics, ADCs, and CAR-T cells reprogram immunosuppressive myeloid niches and block leukemic infiltration, restoring macrophage phagocytosis and antitumor immunity. Combination with anti-PD-(L)1 therapies or chemotherapy is investigated in clinical trials to overcome resistance.
      Human LILRB1 Protein Expression Analysis in Blood of LILRB2/LILRB3/LILRB1/LILRB4 Humanized Transgenic Mice
      • Human LILRB1 was specifically detected on B cells and NK cells in LILRB2/LILRB3/LILRB1/LILRB4 humanized transgenic mice but not wild-type mice.

      Strain specific human LILRB1 expression analysis in LILRB2/LILRB3/LILRB1/LILRB4 humanized transgenic mice by flow cytometry. Blood cells were collected from wild-type C57BL/6 mice (+/+) and transgenic B-Tg(hLILRB2/hLILRB3/hLILRB1/hLILRB4) mice (Tg). Human LILRB1 expression was analyzed by flow cytometry using anti-human LILRB1 antibody (eBioscience™, 17-5129-41).

      • Human LILRB1 was specifically detected on macrophages and DCs in LILRB2/LILRB3/LILRB1/LILRB4 humanized transgenic mice but not wild-type mice.

      Strain specific hLILRB1 expression analysis in LILRB2/LILRB3/LILRB1/LILRB4 humanized transgenic mice by flow cytometry. Blood cells were collected from wild-type C57BL/6 mice (+/+) and transgenic B-Tg(hLILRB2/hLILRB3/hLILRB1/hLILRB4) mice (Tg). Human LILRB1 expression was analyzed by flow cytometry using anti-human LILRB1 antibody (eBioscience™, 17-5129-41).

      Human LILRB2 Protein Expression Analysis in Blood of LILRB2/LILRB3/LILRB1/LILRB4 Humanized Transgenic Mice
      • Human LILRB2 was specifically detected on granulocytes in LILRB2/LILRB3/LILRB1/LILRB4 humanized transgenic mice but not wild-type mice.

      Strain specific hLILRB2 expression analysis in  LILRB2/LILRB3/LILRB1/LILRB4 humanized transgenic mice by flow cytometry. Blood cells were collected from wild-type C57BL/6 mice (+/+) and transgenic B-Tg(hLILRB2/hLILRB3/hLILRB1/hLILRB4) mice (Tg). Human LILRB2 expression was analyzed by flow cytometry using anti-human LILRB2 antibody (R&D, FAB2078P).

      • Human LILRB2 was specifically detected on macrophages and DCs in LILRB2/LILRB3/LILRB1/LILRB4 humanized transgenic mice but not wild-type mice.

      Strain specific hLILRB2 expression analysis in LILRB2/LILRB3/LILRB1/LILRB4 humanized transgenic mice by flow cytometry. Blood cells were collected from wild-type C57BL/6 mice (+/+) and transgenic B-Tg(hLILRB2/hLILRB3/hLILRB1/hLILRB4) mice (Tg). Human LILRB2 expression was analyzed by flow cytometry using anti-human LILRB2 antibody (R&D, FAB2078P).

      Human LILRB3 Protein Expression Analysis in Blood of LILRB2/LILRB3/LILRB1/LILRB4 Humanized Transgenic Mice
      • Human LILRB3 was specifically detected on T cells, B cells, NK cells and granulocytes in LILRB2/LILRB3/LILRB1/LILRB4 humanized transgenic mice but not wild-type mice.

      Strain specific hLILRB3 expression analysis in LILRB2/LILRB3/LILRB1/LILRB4 humanized transgenic mice by flow cytometry. Blood cells were collected from wild-type C57BL/6 mice (+/+) and transgenic B-Tg(hLILRB2/hLILRB3/hLILRB1/hLILRB4) mice (Tg). Human LILRB3 expression was analyzed by flow cytometry using anti-human LILRB3 antibody (R&D, FAB1806P-100).

      • Human LILRB3 was specifically detected on monocytes, macrophages and DCs in LILRB2/LILRB3/LILRB1/LILRB4 humanized transgenic mice but not wild-type mice.

      Strain specific hLILRB3 expression analysis in LILRB2/LILRB3/LILRB1/LILRB4 humanized transgenic mice by flow cytometry. Blood cells were collected from wild-type C57BL/6 mice (+/+) and transgenic B-Tg(hLILRB2/hLILRB3/hLILRB1/hLILRB4) mice (Tg). Human LILRB3 expression was analyzed by flow cytometry using anti-human LILRB3 antibody (R&D, FAB1806P-100).

      Human LILRB4 Protein Expression Analysis in Blood of LILRB2/LILRB3/LILRB1/LILRB4 Humanized Transgenic Mice
      • Human LILRB4 was specifically detected on B cells in LILRB2/LILRB3/LILRB1/LILRB4 humanized transgenic mice but not wild-type mice.

      Strain specific hLILRB4 expression analysis in LILRB2/LILRB3/LILRB1/LILRB4 humanized transgenic mice by flow cytometry. Blood cells were collected from wild-type C57BL/6 mice (+/+) and transgenic B-Tg(hLILRB2/hLILRB3/hLILRB1/hLILRB4) mice (Tg). Human LILRB4 expression was analyzed by flow cytometry using anti-human LILRB4 antibody (R&D, FAB24251P).

      • Human LILRB4 was specifically detected on macrophages and DCs in LILRB2/LILRB3/LILRB1/LILRB4 humanized transgenic mice but not wild-type mice.

      Strain specific hLILRB4 expression analysis in LILRB2/LILRB3/LILRB1/LILRB4 humanized transgenic mice by flow cytometry. Blood cells were collected from wild-type C57BL/6 mice (+/+) and transgenic B-Tg(hLILRB2/hLILRB3/hLILRB1/hLILRB4) mice (Tg). Human LILRB4 expression was analyzed by flow cytometry using anti-human LILRB4 antibody (R&D, FAB24251P).

      Human LILRB1, LILRB2, LILRB3 and LILRB4 Protein Expression Analysis in different organs of LILRB2/LILRB3/LILRB1/LILRB4 Humanized Transgenic Mice
      • Human LILRB1 was specifically detected in liver, spleen, lung, kidney, large intestine, small intestine, brain, ovary and skin of LILRB2/LILRB3/LILRB1/LILRB4 humanized transgenic mice.

      Strain specific hLILRB1 expression analysis in LILRB2/LILRB3/LILRB1/LILRB4 humanized transgenic mice by flow cytometry. Heart, liver, spleen, lung, kidney, large intestine, small intestine, stomach, brain, ovary, and skin were collected from transgenic B-Tg(hLILRB1/hLILRB2/hLILRB3/hLILRB4) mice (female, 8-week-old, n=3). Human LILRB1 expression was analyzed by flow cytometry using  anti-human LILRB1 antibody (eBioscience™, 17-5129-41). (A). Representative FACS plots. (B). Results of FACS analysis. Values are expressed as mean ± SEM.

      • Human LILRB2 was specifically detected in liver, spleen, lung, ovary and skin of LILRB2/LILRB3/LILRB1/LILRB4 humanized transgenic mice.

      Strain specific hLILRB2 expression analysis in LILRB2/LILRB3/LILRB1/LILRB4 humanized transgenic mice by flow cytometry. Heart, liver, spleen, lung, kidney, large intestine, small intestine, stomach, brain, ovary, and skin were collected from transgenic B-Tg(hLILRB1/hLILRB2/hLILRB3/hLILRB4) mice (female, 8-week-old, n=3). Human LILRB2 expression was analyzed by flow cytometry using  anti-human LILRB2 antibody (R&D, FAB2078P). (A). Representative FACS plots. (B). Results of FACS analysis. Values are expressed as mean ± SEM.

      • Human LILRB3 was specifically detected in liver, spleen, lung, kidney, large intestine, brain and skin of LILRB2/LILRB3/LILRB1/LILRB4 humanized transgenic mice.

      Strain specific hLILRB3 expression analysis in LILRB2/LILRB3/LILRB1/LILRB4 humanized transgenic mice by flow cytometry. Heart, liver, spleen, lung, kidney, large intestine, small intestine, stomach, brain, ovary, and skin were collected from transgenic B-Tg(hLILRB1/hLILRB2/hLILRB3/hLILRB4) mice. Human LILRB3 expression was analyzed by flow cytometry using  anti-human LILRB3 antibody (R&D, FAB1806P-100). (A). Representative FACS plots. (B). Results of FACS analysis. Values are expressed as mean ± SEM.

      • Human LILRB4 was specifically detected in liver, spleen, lung, kidney, large intestine, brain, ovary and skin of LILRB2/LILRB3/LILRB1/LILRB4 humanized transgenic mice.

      Strain specific hLILRB4 expression analysis in LILRB2/LILRB3/LILRB1/LILRB4 humanized transgenic mice by flow cytometry. Heart, liver, spleen, lung, kidney, large intestine, small intestine, stomach, brain, ovary, and skin were collected from transgenic B-Tg(hLILRB1/hLILRB2/hLILRB3/hLILRB4) mice. Human LILRB4 expression was analyzed by flow cytometry using  anti-human LILRB3 antibody (R&D, FAB24251P). (A). Representative FACS plots. (B). Results of FACS analysis. Values are expressed as mean ± SEM.

      Animal State Evaluation-Leukocyte Profiling in LILRB2/LILRB3/LILRB1/LILRB4 Humanized Transgenic Mice
      • The frequencies of T cells, B cells, NK cells, CD4+ T cells, CD8+ T cells, granulocyes, DCs, macrophages and monocytes in LILRB2/LILRB3/LILRB1/LILRB4 humanized transgenic mice were similar to those in C57BL/6 mice.

      Analysis of leukocyte subpopulations by flow cytometry in immune organs and blood. Splenocytes, lymph nodes, peripheral blood, and bone marrow were isolated from wild-type C57BL/6 mice and B-Tg(hLILRB2/hLILRB3/hLILRB1/hLILRB4) mice (female, 8-week-old, n=3). Single live cells were gated on the CD45⁺ population and analyzed by flow cytometry as indicated. Values are expressed as mean ± SEM.

      Animal State Evaluation-Analysis of T Cell Subpopulations in LILRB2/LILRB3/LILRB1/LILRB4 Humanized Transgenic Mice
      • The frequencies of CD4⁺ T cells, CD8⁺ T cells, and Tregs in LILRB2/LILRB3/LILRB1/LILRB4 humanized transgenic mice were similar to those in C57BL/6 mice.

      Analysis of T-cell subpopulations by flow cytometry in immune organs and blood. Splenocytes, lymph nodes, peripheral blood, and bone marrow were isolated from wild-type C57BL/6 mice and B-Tg(hLILRB2/hLILRB3/hLILRB1/hLILRB4) mice (female, 8-week-old, n=3). Single live cells were gated on the CD45⁺ CD3⁺ T cellspopulation and analyzed by flow cytometry as indicated. Values are expressed as mean ± SEM.

      In Vivo Efficacy of anti-HLA-G Antibodies Antibodies in LILRB2/LILRB3/LILRB1/LILRB4 Humanized Transgenic Mice

      Establishment of a B-hB2M/HLA-G MC38 model and in vivo efficacy study of anti-HLA-G antibodies. B-hB2M/HLA-G MC38 cells were inoculated subcutaneously into transgenic B-Tg(hLILRB2/hLILRB3/hLILRB1/hLILRB4) mice (female, 6-8 weeks old, n = 4). When the average tumor volume reached approximately 79 mm³, mice were randomized and subsequently administered the anti-HLA-G antibodies via intraperitoneal injection.

      Antitumor activity of anti-HLA-G antibodies in LILRB2/LILRB3/LILRB1/LILRB4 humanized transgenic mice. (A) Anti-human HLA-G antibodies inhibited MC38 tumor growth in B-Tg(hLILRB2/hLILRB3/hLILRB1/hLILRB4) mice. Murine colon cancer B-hB2M/HLA-G MC38 cells (5 × 105) were subcutaneously implanted into B-Tg(hLILRB2/hLILRB3/hLILRB1/hLILRB4) mice (female, 6-7 weeks old, n = 4). Tumor-bearing animals were randomly enrolled into four study groups when the mean tumor size reached 79 mm3, at which time they were intraperitoneally injected with anti-HLA-G antibodies (provided by a client) indicated in the panel. (B) Body weight changes during treatment. As shown in panel A, the anti-HLA-G antibodies inhibited tumor growth in B-Tg(hLILRB2/hLILRB3/hLILRB1/hLILRB4) mice. Values are expressed as mean ± SEM.

      Frequently Asked Questions (FAQs) About in LILRB2/LILRB3/LILRB1/LILRB4 Humanized Transgenic Mice (B-Tg(hLILRB2/hLILRB3/hLILRB1/hLILRB4))

      Q1: How were LILRB2/LILRB3/LILRB1/LILRB4 humanized transgenic mice generated/developed?

      A1: The LILRB2/LILRB3/LILRB1/LILRB4 humanized transgenic mice was obtained by mating LILRB2/LILRB3 humanized transgenic mice and LILRB1/LILRB4 humanized transgenic mice.

      Q2: What were the differences of LIRB1-4 protein expression between LILRB2/LILRB3/LILRB1/LILRB4 humanized transgenic mice and humans?

      A2: Protein expression in different immune cells: LILRB1 leaks on neutrophils; LILRB2 expression profile is consistent with human; LILRB3 leaks on NK; LILRB4 leaks on B cells.

      * When publishing results obtained using this animal model, please acknowledge the source as follows: The animal model [B-Tg(hLILRB2/hLILRB3/hLILRB1/hLILRB4) mice] (Cat# 112332) was purchased from Biocytogen.